Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Acadia Healthcare Company, Inc. (ACHC)

Compare
30.37
+0.25
+(0.83%)
As of 10:08:41 AM EDT. Market Open.
Loading Chart for ACHC
  • Previous Close 30.12
  • Open 30.06
  • Bid 30.33 x 100
  • Ask 30.54 x 300
  • Day's Range 29.90 - 30.39
  • 52 Week Range 27.61 - 82.41
  • Volume 72,145
  • Avg. Volume 1,839,556
  • Market Cap (intraday) 2.822B
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) 10.92
  • EPS (TTM) 2.78
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 49.46

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

www.acadiahealthcare.com

19,192

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACHC

View More

Performance Overview: ACHC

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ACHC
23.40%
S&P 500 (^GSPC)
4.04%

1-Year Return

ACHC
61.66%
S&P 500 (^GSPC)
7.41%

3-Year Return

ACHC
54.59%
S&P 500 (^GSPC)
23.35%

5-Year Return

ACHC
68.44%
S&P 500 (^GSPC)
122.07%

Compare To: ACHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACHC

View More

Valuation Measures

Annual
As of 3/27/2025
  • Market Cap

    2.80B

  • Enterprise Value

    4.81B

  • Trailing P/E

    10.83

  • Forward P/E

    11.49

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    1.52

  • Enterprise Value/EBITDA

    7.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.10%

  • Return on Assets (ttm)

    5.77%

  • Return on Equity (ttm)

    8.70%

  • Revenue (ttm)

    3.15B

  • Net Income Avi to Common (ttm)

    255.61M

  • Diluted EPS (ttm)

    2.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    76.31M

  • Total Debt/Equity (mrq)

    65.69%

  • Levered Free Cash Flow (ttm)

    -605.91M

Research Analysis: ACHC

View More

Company Insights: ACHC

Research Reports: ACHC

View More

People Also Watch